Loading…
Bicara Therapeutics Inc. is projected to rise to $28.68 by 2027, a +33% move from its current price of $21.58. BCAX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $21.07 | $21.59 | $22.12 | +0.03% |
| May 30 | $20.86 | $21.59 | $22.35 | +0.05% |
| May 31 | $20.71 | $21.60 | $22.52 | +0.08% |
| Jun 1 | $20.58 | $21.60 | $22.68 | +0.11% |
| Jun 2 | $20.47 | $21.61 | $22.81 | +0.14% |
| Jun 3 | $20.37 | $21.62 | $22.94 | +0.16% |
| Jun 4 | $20.28 | $21.62 | $23.06 | +0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $20.28 | $21.62 | $23.06 | +0.19% |
| Week 2 | $19.78 | $21.66 | $23.72 | +0.38% |
| Week 3 | $19.42 | $21.70 | $24.26 | +0.57% |
| Week 4 | $19.12 | $21.74 | $24.72 | +0.76% |
| Week 5 | $18.87 | $21.79 | $25.15 | +0.95% |
| Week 6 | $18.65 | $21.83 | $25.55 | +1.15% |
| Week 7 | $18.45 | $21.87 | $25.92 | +1.34% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bicara Therapeutics Inc. is a clinical-stage biopharmaceutical company that develops bifunctional therapies for solid tumors.
Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors.
The company was incorporated in 2018 and is based in Boston, Massachusetts.
Bicara Therapeutics Inc. (BCAX) trades at $21.68, has a market cap of $1.42B, and is ranked 2273.
The stock sits within a 30-day range of $18.34 to $25.62.
Forecasts show upside over time. The 2026 average price is $21.68 with ROI 0 and sentiment NEUTRAL; the 2027 average is $28.38 with ROI 30.9 and sentiment BULLISH; the 2028 average is $36.33 with ROI 67.6 and sentiment BULLISH; the 2029 average is $43.92 with ROI 102.6 and sentiment BULLISH; the 2030 average is $50.03 with ROI 130.8 and sentiment BULLISH; the 2031 average is $56.07 with ROI 158.6 and sentiment BULLISH; the 2032 average is $58.51 with ROI 169.9 and sentiment BULLISH; the 2033 average is $64.81 with ROI 198.9 and sentiment BULLISH; the 2034 average is $76.29 with ROI 251.9 and sentiment BULLISH; the 2035 average is $92.38 with ROI 326.1 and sentiment BULLISH; the 2040 average is $128.94 with ROI 494.8 and sentiment BULLISH; the 2050 average is $301.69 with ROI 1291.5 and sentiment BULLISH.
A major floor 34.8% below — a decisive break under it would weaken the trend.
The nearest floor, 10.6% below — buyers have tended to step in here.
The nearest ceiling, 11.3% above — a clean break opens room to run.
A major ceiling 22.1% above — clearing it would confirm fresh momentum.
Key BCAX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BCAX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $21.30 | Buy | $21.38 | Buy |
| MA 10 | $20.77 | Buy | $21.29 | Buy |
| MA 20 | $21.64 | Sell | $21.47 | Buy |
| MA 50 | $21.30 | Buy | $20.98 | Buy |
| MA 100 | $19.09 | Buy | $19.67 | Buy |
| MA 200 | $17.10 | Buy | $18.04 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.81 | Neutral |
| Stoch RSI (14) | 68.97 | Neutral |
| CCI (20) | -4.41 | Neutral |
| Williams %R (14) | -39.74 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -4.43 | Sell |
| Bollinger %B (20,2) | 0.49 | Neutral |
| Stochastic %K (14) | 60.26 | Neutral |
| TRIX (15) | -0.08 | Sell |
| Awesome (5,34) | -0.84 | Sell |
| Ultimate (7,14,28) | 54.62 | Neutral |
| Momentum (10) | -0.80 | Sell |
| Aroon Osc (25) | -32.00 | Sell |
| Hull MA (9) | 22.05 | Sell |
| ADX (14) | 15.74 | Neutral |
| ATR (14) | 0.55 | Info |
The 30-day technical picture is bullish.
RSI14 is 50, the SMA50 is $21.20, and the SMA200 is $16.99.
Support is at $19.29 and resistance at $24.01, with a 30-day range of $18.34 to $25.62.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $14.06 | $21.58 | $30.06 | 0% | Neutral | |
| $22.99 | $28.68 | $37.75 | +33% | Bullish | |
| $29.01 | $37.06 | $50.38 | +72% | Bullish | |
| $34.18 | $44.54 | $62.12 | +106% | Bullish | |
| $38.73 | $51.37 | $73.22 | +138% | Bullish | |
| $43.04 | $58.01 | $84.26 | +169% | Bullish | |
| $44.36 | $60.69 | $89.68 | +181% | Bullish | |
| $49.16 | $68.20 | $102.36 | +216% | Bullish | |
| $57.09 | $80.26 | $122.21 | +272% | Bullish | |
| $67.87 | $96.64 | $149.13 | +348% | Bullish | |
| $92.07 | $138.83 | $226.65 | +543% | Bullish | |
| $194.78 | $323.77 | $574.21 | +14.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $14.06 | $21.58 | $25.44 | +0.00% |
| June 2026 | $19.09 | $22.37 | $26.79 | +3.65% |
| July 2026 | $18.74 | $22.12 | $26.81 | -1.11% |
| August 2026 | $18.60 | $22.08 | $27.01 | -0.17% |
| September 2026 | $19.16 | $22.86 | $28.18 | +3.52% |
| October 2026 | $19.38 | $23.22 | $28.82 | +1.59% |
| November 2026 | $19.22 | $23.12 | $28.86 | -0.45% |
| December 2026 | $19.83 | $23.94 | $30.06 | +3.56% |
Click any year to see its month-by-month BCAX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BCAX price prediction for 2026 points to an average of $21.58 (low $14.06, high $30.06) — a potential gain of 0% on today's $21.58. A consolidation phase looks the most probable path here.
In 2027, BCAX is projected to trade between $22.99 and $37.75, averaging $28.68 — a potential gain of +33% from today's $21.58. That is up +33% on the projected 2026 average. Momentum favours further upside here.
Bicara Therapeutics Inc.'s 2028 outlook centres on $37.06, within a $29.01 to $50.38 range. That is up +29% on the projected 2027 average. That marks a +72% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, BCAX could reach as high as $62.12, with a base case around $44.54 and support toward $34.18 — roughly +106% from $21.58. Momentum favours further upside here.
Expect BCAX to range from $38.73 to $73.22 through 2030. The $51.37 average target implies a +138% move from current prices. That is up +15% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The BCAX price prediction for 2031 points to an average of $58.01 (low $43.04, high $84.26) — a potential gain of +169% on today's $21.58. Momentum favours further upside here.
In 2032, BCAX is projected to trade between $44.36 and $89.68, averaging $60.69 — a potential gain of +181% from today's $21.58. That is up +5% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Bicara Therapeutics Inc.'s 2033 outlook centres on $68.20, within a $49.16 to $102.36 range. That is up +12% on the projected 2032 average. That marks a +216% change versus current levels. Momentum favours further upside here.
By 2034, BCAX could reach as high as $122.21, with a base case around $80.26 and support toward $57.09 — roughly +272% from $21.58. Buyers look set to stay in control over this stretch.
Expect BCAX to range from $67.87 to $149.13 through 2035. The $96.64 average target implies a +348% move from current prices. That is up +20% on the projected 2034 average. Momentum favours further upside here.
The BCAX price prediction for 2040 points to an average of $138.83 (low $92.07, high $226.65) — a potential gain of +543% on today's $21.58. Buyers look set to stay in control over this stretch.
In 2050, BCAX is projected to trade between $194.78 and $574.21, averaging $323.77 — a potential gain of +14.0x from today's $21.58. That is up +133% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BCAX today (≈ 46.339203 BCAX) could be worth
$15,003.38
+$14,003.38 (+1400%) by 2050 · US Dollar
Based on the average projected BCAX price of $323.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BCAXwould be worth at today's price.
$1,000 invested in BCAX on May 27, 2025 (≈ 100.200405 BCAX) would be worth
$2,162.32
+$1,162.32 (+116.2%) today · 2.16× · US Dollar
Based on a BCAX entry price of $9.98 vs. today's $21.58.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $20.43 | $1,056.29 | +5.6% |
| 1 month ago | $22.48 | $960.18 | -4.0% |
| 3 months ago | $16.8 | $1,284.52 | +28.5% |
| 6 months ago | $18.56 | $1,162.72 | +16.3% |
| 1 year ago | $9.98 | $2,162.32 | +116.2% |
| All time (1.7y) ago | $23.41 | $921.83 | -7.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BCAX forecast.
Our base-case forecast reaches $43.00 around 2029.
Implied market cap at $43.00: $2.83B
The multi-year forecast shows strong upside with 2030 avg $50.03 (ROI 130.8) and 2040 avg $128.94 (ROI 494.8) and 2050 avg $301.69 (ROI 1291.5), all with bullish sentiment.
From 2026 through 2029, averages rise from $21.68 to $43.92, with increasing ROI and bullish sentiment.
These are estimates, not guarantees, and actual results depend on multiple factors.
Tap a question to reveal the answer.
2030 avg $50.03, min $37.46, max $71.91; ROI 130.8%; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages and ROIs up to 1291.5% by 2050; these are estimates, not guarantees.
Yes—the forecast includes a 2035 max of $144.14 and a 2040 max of $213.24, with a 2050 max of $543.25, indicating possible upside above $100 under the scenarios provided.
Current price $21.68; Market cap $1.42B.
30-day range low $18.34, high $25.62.
Bicara Therapeutics Inc. Community Discussion
0Share your Bicara Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.